124 related articles for article (PubMed ID: 11714603)
21. Novel heterocyclic family of phenyl naphthothiazole carboxamides derived from naphthalimides: synthesis, antitumor evaluation, and DNA photocleavage.
Li Z; Yang Q; Qian X
Bioorg Med Chem; 2005 May; 13(9):3149-55. PubMed ID: 15809150
[TBL] [Abstract][Full Text] [Related]
22. 1-Methoxy-agroclavine from Penicillium sp. WC75209, a novel inhibitor of the Lck tyrosine kinase.
Padmanabha R; Shu YZ; Cook LS; Veitch JA; Donovan M; Lowe S; Huang S; Pirnik D; Manly SP
Bioorg Med Chem Lett; 1998 Mar; 8(6):569-74. PubMed ID: 9871562
[TBL] [Abstract][Full Text] [Related]
23. Discovery and initial SAR of imidazoquinoxalines as inhibitors of the Src-family kinase p56(Lck).
Chen P; Norris D; Iwanowicz EJ; Spergel SH; Lin J; Gu HH; Shen Z; Wityak J; Lin TA; Pang S; De Fex HF; Pitt S; Shen DR; Doweyko AM; Bassolino DA; Roberge JY; Poss MA; Chen BC; Schieven GL; Barrish JC
Bioorg Med Chem Lett; 2002 May; 12(10):1361-4. PubMed ID: 11992777
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and Src kinase inhibitory activity of a series of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitriles.
Boschelli DH; Wu B; Ye F; Wang Y; Golas JM; Lucas J; Boschelli F
J Med Chem; 2006 Dec; 49(26):7868-76. PubMed ID: 17181170
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, biological activity, and quantitative structure-activity relationship study of azanaphthalimide and arylnaphthalimide derivatives.
Braña MF; Gradillas A; Gómez A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle F; Yuste M; Campos J; Gallo MA; Espinosa A
J Med Chem; 2004 Apr; 47(9):2236-42. PubMed ID: 15084122
[TBL] [Abstract][Full Text] [Related]
26. Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck II.
Burchat AF; Calderwood DJ; Hirst GC; Holman NJ; Johnston DN; Munschauer R; Rafferty P; Tometzki GB
Bioorg Med Chem Lett; 2000 Oct; 10(19):2171-4. PubMed ID: 11012022
[TBL] [Abstract][Full Text] [Related]
27. Effects of cantharidinimides on human carcinoma cells.
Lin LH; Huang HS; Lin CC; Lee LW; Lin PY
Chem Pharm Bull (Tokyo); 2004 Jul; 52(7):855-7. PubMed ID: 15256708
[TBL] [Abstract][Full Text] [Related]
28. Solvent free, catalyst free, microwave or grinding assisted synthesis of bis-cyclic imide derivatives and their evaluation for anticancer activity.
Kumar A; Banerjee S; Roy P; Sondhi SM; Sharma A
Bioorg Med Chem Lett; 2017 Feb; 27(3):501-504. PubMed ID: 28011220
[TBL] [Abstract][Full Text] [Related]
29. Validated quantitative structure-activity relationship analysis of a series of 2-aminothiazole based p56(Lck) inhibitors.
Li J; Du J; Xi L; Liu H; Yao X; Liu M
Anal Chim Acta; 2009 Jan; 631(1):29-39. PubMed ID: 19046675
[TBL] [Abstract][Full Text] [Related]
30. Structure-based design of peptidomimetic antagonists of p56(lck) SH2 domain.
Hobbs CJ; Bit RA; Cansfield AD; Harris B; Hill CH; Hilyard KL; Kilford IR; Kitas E; Kroehn A; Lovell P; Pole D; Rugman P; Sherborne BS; Smith IE; Vesey DR; Walmsley DL; Whittaker D; Williams G; Wilson F; Banner D; Surgenor A; Borkakoti N
Bioorg Med Chem Lett; 2002 May; 12(10):1365-9. PubMed ID: 11992778
[TBL] [Abstract][Full Text] [Related]
31. Optimization of 2-phenylaminoimidazo[4,5-h]isoquinolin-9-ones: orally active inhibitors of lck kinase.
Goldberg DR; Butz T; Cardozo MG; Eckner RJ; Hammach A; Huang J; Jakes S; Kapadia S; Kashem M; Lukas S; Morwick TM; Panzenbeck M; Patel U; Pav S; Peet GW; Peterson JD; Prokopowicz AS; Snow RJ; Sellati R; Takahashi H; Tan J; Tschantz MA; Wang XJ; Wang Y; Wolak J; Xiong P; Moss N
J Med Chem; 2003 Apr; 46(8):1337-49. PubMed ID: 12672234
[TBL] [Abstract][Full Text] [Related]
32. N-4-Pyrimidinyl-1H-indazol-4-amine inhibitors of Lck: indazoles as phenol isosteres with improved pharmacokinetics.
Bamborough P; Angell RM; Bhamra I; Brown D; Bull J; Christopher JA; Cooper AW; Fazal LH; Giordano I; Hind L; Patel VK; Ranshaw LE; Sims MJ; Skone PA; Smith KJ; Vickerstaff E; Washington M
Bioorg Med Chem Lett; 2007 Aug; 17(15):4363-8. PubMed ID: 17600705
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, structure and antitumor activity of new benz[d,e]isoquinoline-1,3-diones.
Braña MF; Castellano JM; Morán M; Emling F; Kluge M; Schlick E; Klebe G; Walker N
Arzneimittelforschung; 1995 Dec; 45(12):1311-8. PubMed ID: 8595091
[TBL] [Abstract][Full Text] [Related]
34. Targeting ribosomal G-quadruplexes with naphthalene-diimides as RNA polymerase I inhibitors for colorectal cancer treatment.
Sanchez-Martin V; Schneider DA; Ortiz-Gonzalez M; Soriano-Lerma A; Linde-Rodriguez A; Perez-Carrasco V; Gutierrez-Fernandez J; Cuadros M; González C; Soriano M; Garcia-Salcedo JA
Cell Chem Biol; 2021 Nov; 28(11):1590-1601.e4. PubMed ID: 34166611
[TBL] [Abstract][Full Text] [Related]
35. The synthesis and in vitro cytotoxic studies of novel bis-naphthalimidopropyl polyamine derivatives.
Lin PK; Pavlov VA
Bioorg Med Chem Lett; 2000 Jul; 10(14):1609-12. PubMed ID: 10915063
[TBL] [Abstract][Full Text] [Related]
36. Superelectrophiles in Synthesis: Preparation of Aromatic Imides.
Kennedy SH; Schaeff MN; Klumpp DA
J Org Chem; 2019 Nov; 84(21):14133-14140. PubMed ID: 31571485
[TBL] [Abstract][Full Text] [Related]
37. A new diimide derivative from the co-culture broth of two mangrove fungi (strain no. E33 and K38).
Li CY; Ding WJ; Shao CL; She ZG; Lin YC
J Asian Nat Prod Res; 2010 Sep; 12(9):809-13. PubMed ID: 20839130
[TBL] [Abstract][Full Text] [Related]
38. Development of N-4,6-pyrimidine-N-alkyl-N'-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase.
Maier JA; Brugel TA; Sabat M; Golebiowski A; Laufersweiler MJ; VanRens JC; Hopkins CR; De B; Hsieh LC; Brown KK; Easwaran V; Janusz MJ
Bioorg Med Chem Lett; 2006 Jul; 16(14):3646-50. PubMed ID: 16682201
[TBL] [Abstract][Full Text] [Related]
39. Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity.
Martin MW; Newcomb J; Nunes JJ; Boucher C; Chai L; Epstein LF; Faust T; Flores S; Gallant P; Gore A; Gu Y; Hsieh F; Huang X; Kim JL; Middleton S; Morgenstern K; Oliveira-dos-Santos A; Patel VF; Powers D; Rose P; Tudor Y; Turci SM; Welcher AA; Zack D; Zhao H; Zhu L; Zhu X; Ghiron C; Ermann M; Johnston D; Saluste CG
J Med Chem; 2008 Mar; 51(6):1637-48. PubMed ID: 18278858
[TBL] [Abstract][Full Text] [Related]
40. Pyrrolo[2,3-d]pyrimidines containing diverse N-7 substituents as potent inhibitors of Lck.
Calderwood DJ; Johnston DN; Munschauer R; Rafferty P
Bioorg Med Chem Lett; 2002 Jun; 12(12):1683-6. PubMed ID: 12039590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
